Holocene Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,078
Closed -$478K 809
2024
Q4
$478K Buy
+21,078
New +$460K ﹤0.01% 715
2024
Q3
Sell
-42,680
Closed -$1.24M 791
2024
Q2
$1.24M Buy
+42,680
New +$1.27M 0.01% 589
2023
Q4
Sell
-77,477
Closed -$2.96M 763
2023
Q3
$2.96M Buy
+77,477
New +$3.26M 0.01% 492
2022
Q4
Sell
-45,701
Closed -$1.94M 795
2022
Q3
$1.94M Buy
+45,701
New +$2.34M 0.01% 428
2022
Q2
Sell
-14,322
Closed -$920K 905
2022
Q1
$920K Sell
14,322
-18,503
-56% -$1.22M ﹤0.01% 705
2021
Q4
$2.2M Buy
32,825
+10,149
+45% +$687K 0.01% 500
2021
Q3
$1.55M Buy
+22,676
New +$1.6M 0.01% 601
2021
Q1
Sell
-32,109
Closed -$2.08M 858
2020
Q4
$2.08M Buy
32,109
+6,610
+26% +$356K 0.01% 412
2020
Q3
$1.2M Buy
25,499
+17,034
+201% +$810K 0.01% 470
2020
Q2
$398K Sell
8,465
-3,019
-26% -$148K ﹤0.01% 541
2020
Q1
$513K Buy
+11,484
New +$603K 0.01% 546
2019
Q3
Sell
-12,831
Closed -$717K 776
2019
Q2
$717K Buy
12,831
+998
+8% +$51.4K 0.01% 369
2019
Q1
$659K Buy
11,833
+4,077
+53% +$208K 0.01% 353
2018
Q4
$350K Sell
7,756
-4,587
-37% -$252K 0.01% 516
2018
Q3
$813K Buy
+12,343
New +$767K 0.01% 389

Other funds holding IART

Holocene Advisors's IART Position: Q1 2025 in Review

Holocene Advisors sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 21,078 shares — an estimated $478K sold.

Holocene Advisors first reported a position in IART in Q3 2018 and held it in 15 quarters. The position peaked at $2.96M in Q3 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Holocene Advisors reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Holocene Advisors sold 21,078 Integra LifeSciences shares in Q1 2025, an estimated $478K.
  • Holocene Advisors first reported a position in Integra LifeSciences in Q3 2018 and held it in 15 quarters.
  • Holocene Advisors's Integra LifeSciences position peaked at $2.96M in Q3 2023.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Holocene Advisors's 13F filing for Q1 2025, filed 15 May 2025.